Riskier blood thinner used more often in Black patients; psychiatric issues linked to COVID-19
A new analysis of the use of blood thinners in hospitalized COVID-19 patients highlights a striking racial disparity that may help further explain why Black patients are hit harder by the disease. The anticoagulant enoxaparin - sold under the brand name Lovenox - which is associated with superior COVID

Full story is loading. Click here if it doesn't...